BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar G, Adams A, Hererra M, Rojas ER, Singh V, Sakhuja A, Meersman M, Dalton D, Kethireddy S, Nanchal R, Guddati AK. Predictors and outcomes of healthcare-associated infections in COVID-19 patients. Int J Infect Dis 2021;104:287-92. [PMID: 33207271 DOI: 10.1016/j.ijid.2020.11.135] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Bussolati E, Cultrera R, Quaranta A, Cricca V, Marangoni E, La Rosa R, Bertacchini S, Bellonzi A, Ragazzi R, Volta CA, Spadaro S, Scaramuzzo G. Effect of the Pandemic Outbreak on ICU-Associated Infections and Antibiotic Prescription Trends in Non-COVID19 Acute Respiratory Failure Patients. JCM 2022;11:7080. [DOI: 10.3390/jcm11237080] [Reference Citation Analysis]
2 Gasch O, Badia-cebada L, Carmezim J, Vaqué M, Pomar V, Moreno E, Marrón A, Jiménez-martínez E, García-quesada MJ, Garcia-alarcón X, Domènech D, Càmara J, Andrés M, Peñafiel J, Porrón R, Limón E, Calbo E, Pujol M. Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, Spain. Emerg Infect Dis 2022;28:2181-2189. [DOI: 10.3201/eid2811.220547] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wu HY, Chang PH, Chen KY, Lin IF, Hsih WH, Tsai WL, Chen JA, Lee SS; GREAT working group. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment. J Microbiol Immunol Infect 2022:S1684-1182(22)00157-8. [PMID: 36243668 DOI: 10.1016/j.jmii.2022.09.006] [Reference Citation Analysis]
4 Colaneri M, Asperges E, Calia M, Sacchi P, Rettani M, Cutti S, Albi G, Bruno R. Despite Vaccination: A Real-Life Experience of Severe and Life-Threatening COVID-19 in Vaccinated and Unvaccinated Patients. Vaccines (Basel) 2022;10:1540. [PMID: 36146618 DOI: 10.3390/vaccines10091540] [Reference Citation Analysis]
5 Tyagi A, Grover S, Bansal R. Changing faces and habitat of mucormycosis epidemic in sequential COVID waves. IJPO 2022;9:227-231. [DOI: 10.18231/j.ijpo.2022.054] [Reference Citation Analysis]
6 Deiana G, Arghittu A, Gentili D, Dettori M, Palmieri A, Masia MD, Azara A, Castiglia P. Impact of the COVID-19 Pandemic on the Prevalence of HAIs and the Use of Antibiotics in an Italian University Hospital. Healthcare 2022;10:1597. [DOI: 10.3390/healthcare10091597] [Reference Citation Analysis]
7 Tracy BM, Valdez CL, Crowley B, Seng S, Ratnasekera A, Collins CM, Bhattacharya B, O'Connor R, Sharp V, Gelbard RB. Academic Medical Centers Experienced Higher Rates of Post-Operative Health-Care-Associated Infections during the COVID-19 Pandemic: A Post Hoc Analysis of an Eastern Association for the Surgery of Trauma Multicenter Trial. Surg Infect (Larchmt) 2022;23:538-44. [PMID: 35917388 DOI: 10.1089/sur.2022.148] [Reference Citation Analysis]
8 Sachdeva S, Dalvi A, Saluja H, Haridas A, Mani A. Coronavirus disease (COVID-19) Associated mucormycosis (CAM). JCB 2022;8:37-42. [DOI: 10.3233/jcb-210046] [Reference Citation Analysis]
9 Mahajan I, Ghose A, Gupta D, Manasvi M, Bhandari S, Das A, Sanchez E, Boussios S. COVID-19, Mucormycosis and Cancer: The Triple Threat-Hypothesis or Reality? J Pers Med 2022;12:1119. [PMID: 35887616 DOI: 10.3390/jpm12071119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ghosh D, Dey S, Chakraborty H, Mukherjee S, Halder A, Sarkar A, Chakraborty P, Ghosh R, Sarkar J. Mucormycosis: A new threat to Coronavirus disease 2019 with special emphasis on India. Clinical Epidemiology and Global Health 2022;15:101013. [DOI: 10.1016/j.cegh.2022.101013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Isonne C, Baccolini V, Migliara G, Ceparano M, Alessandri F, Ceccarelli G, Tellan G, Pugliese F, De Giusti M, De Vito C, Marzuillo C, Villari P, Barone LC, Giannini D, Marotta D, Marte M, Mazzalai E, Germani I, Bellini A, Bongiovanni A, Castellani M, D'Agostino L, De Giorgi A, De Marchi C, Mazzeo E, Orlandi S, Piattoli M, Ricci E, Siena LM, Territo A, Zanni S. Comparing the Occurrence of Healthcare-Associated Infections in Patients with and without COVID-19 Hospitalized during the Pandemic: A 16-Month Retrospective Cohort Study in a Hospital Intensive Care Unit. J Clin Med 2022;11:1446. [PMID: 35268538 DOI: 10.3390/jcm11051446] [Reference Citation Analysis]
12 Kurra N, Woodard PI, Gandrakota N, Gandhi H, Polisetty SR, Ang SP, Patel KP, Chitimalla V, Ali Baig MM, Samudrala G. Opportunistic Infections in COVID-19: A Systematic Review and Meta-Analysis. Cureus 2022;14:e23687. [PMID: 35505698 DOI: 10.7759/cureus.23687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol. [DOI: 10.1007/s12223-021-00934-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Fehér Á, Szarvas Z, Lehoczki A, Fekete M, Fazekas-Pongor V. Co-infections in COVID-19 patients and correlation with mortality rate. Minireview. Physiol Int 2022. [PMID: 35218335 DOI: 10.1556/2060.2022.00015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Rafiei S, Nejatifar Z, Soheylirad R, Raoofi S, Pashazadeh Kan F, Ghashghaee A. Prevalence of Nosocomial Infections During the COVID-19 Pandemic: A Systematic Review and Meta-analysis. J Health Rep Technol 2022;8. [DOI: 10.5812/jhrt-120472] [Reference Citation Analysis]
16 Koritala T, Pattan V, Tirupathi R, Rabaan AA, Al Mutair A, Alhumaid S, Adhikari R, Deepika K, Jain NK, Bansal V, Tekin A, Zec S, Lal A, Khan SA, Garces JPD, Abu Saleh OM, Surani SR, Kashyap R. Infection risk with the use of interleukin inhibitors in hospitalized patients with COVID-19: A narrative review. Infez Med 2021;29:495-503. [PMID: 35146357 DOI: 10.53854/liim-2904-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Erbay K, Ozger HS, Guzel Tunccan O, Gaygısız Ü, Buyukkoruk M, Sultanova F, Yıldız M, Boyacı Dündar N, Aydoğdu M, Bozdayi G, Dizbay M. Evaluation of prevalance and risk factors for bloodstream infection in severe coronavirus disease 2019 (COVID-19) patients. ASHE 2022;2:e30. [DOI: 10.1017/ash.2021.254] [Reference Citation Analysis]
18 Nautiyal A, Bali S, Aggarwal P. Paranasal Mucormycosis: A Literature Review. JPFA 2021;35:106. [DOI: 10.18311/jpfa/2021/28091] [Reference Citation Analysis]
19 Rajni E, Singh A, Tarai B, Jain K, Shankar R, Pawar K, Mamoria V, Chowdhary A. A High Frequency of Candida auris Blood Stream Infections in Coronavirus Disease 2019 Patients Admitted to Intensive Care Units, Northwestern India: A Case Control Study. Open Forum Infect Dis 2021;8:ofab452. [PMID: 34904116 DOI: 10.1093/ofid/ofab452] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
20 Verma A, Rathi B. Machine learning based predictive model and systems-level network of host-microbe interactions in post-COVID-19 mucormycosis. Microb Pathog 2021;162:105324. [PMID: 34861346 DOI: 10.1016/j.micpath.2021.105324] [Reference Citation Analysis]
21 Mushtaq MZ, Mahmood SBZ, Almas A, Ather Wasti S, Ahsan Ali S. Tocilizumab in critically ill COVID-19 patients: An observational study. Int Immunopharmacol 2022;102:108384. [PMID: 34838490 DOI: 10.1016/j.intimp.2021.108384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
22 Langford BJ, So M, Leung V, Raybardhan S, Lo J, Kan T, Leung F, Westwood D, Daneman N, MacFadden DR, Soucy JR. Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. Clin Microbiol Infect 2021:S1198-743X(21)00636-4. [PMID: 34843962 DOI: 10.1016/j.cmi.2021.11.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
23 Méndez L, Ferreira J, Caneiras C. Hafnia alvei Pneumonia: A Rare Cause of Infection in a Patient with COVID-19. Microorganisms 2021;9:2369. [PMID: 34835494 DOI: 10.3390/microorganisms9112369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Torabiyan S, Dalfardi B, Sanjari M. Asymptomatic COVID-19 as a Risk Factor of Diabetic Ketoacidosis and Mucormycosis: A Case Report and Review of the Literature. Case Rep Endocrinol 2021;2021:2765867. [PMID: 34777880 DOI: 10.1155/2021/2765867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Mohanty A, Gupta P, Arathi K, Rao S, Rohilla R, Meena S, Singh A, Kaistha N, Rath RS, Varshney S. Evaluation of Direct Examination, Culture, and Histopathology in the Diagnosis of Mucormycosis: Reiterating the Role of KOH Mount for Early Diagnosis. Cureus. [DOI: 10.7759/cureus.19455] [Reference Citation Analysis]
26 Kumar G, Patel D, Hererra M, Jefferies D, Sakhuja A, Meersman M, Dalton D, Nanchal R, Guddati AK. Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients? J Med Virol 2022;94:372-9. [PMID: 34559436 DOI: 10.1002/jmv.27357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
27 Ippolito M, Simone B, Filisina C, Catalanotto FR, Catalisano G, Marino C, Misseri G, Giarratano A, Cortegiani A. Bloodstream Infections in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Microorganisms 2021;9:2016. [PMID: 34683337 DOI: 10.3390/microorganisms9102016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
28 Zore S. A Review of Coronavirus Disease Covid-19. IJARSCT 2021. [DOI: 10.48175/ijarsct-1929] [Reference Citation Analysis]
29 Weiner-Lastinger LM, Pattabiraman V, Konnor RY, Patel PR, Wong E, Xu SY, Smith B, Edwards JR, Dudeck MA. The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2021;:1-14. [PMID: 34473013 DOI: 10.1017/ice.2021.362] [Cited by in Crossref: 48] [Cited by in F6Publishing: 57] [Article Influence: 48.0] [Reference Citation Analysis]
30 Sopirala MM. Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change? Curr Opin Infect Dis 2021;34:357-64. [PMID: 34039879 DOI: 10.1097/QCO.0000000000000736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Mahalmani V, Kumaravel J, Jain M, Prakash A, Medhi B. Antimicrobial resistance: An unseen threat prowling behind the COVID-19 outbreak. Indian J Pharmacol 2021;53:187-91. [PMID: 34169902 DOI: 10.4103/ijp.ijp_430_21] [Reference Citation Analysis]
32 Singh Y, Ganesh V, Kumar S, Patel N, Aggarwala R, Soni KD, Trikha A. Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series. Cureus 2021;13:e16152. [PMID: 34354889 DOI: 10.7759/cureus.16152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
33 Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS One 2021;16:e0251170. [PMID: 33956882 DOI: 10.1371/journal.pone.0251170] [Cited by in Crossref: 142] [Cited by in F6Publishing: 163] [Article Influence: 142.0] [Reference Citation Analysis]
34 Westblade LF, Simon MS, Satlin MJ. Bacterial coinfections in coronavirus disease 2019. Trends Microbiol 2021:S0966-842X(21)00094-9. [PMID: 33934980 DOI: 10.1016/j.tim.2021.03.018] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 43.0] [Reference Citation Analysis]
35 Patel PR, Weiner-Lastinger LM, Dudeck MA, Fike LV, Kuhar DT, Edwards JR, Pollock D, Benin A. Impact of COVID-19 pandemic on central-line-associated bloodstream infections during the early months of 2020, National Healthcare Safety Network. Infect Control Hosp Epidemiol 2021;:1-4. [PMID: 33719981 DOI: 10.1017/ice.2021.108] [Cited by in Crossref: 19] [Cited by in F6Publishing: 26] [Article Influence: 19.0] [Reference Citation Analysis]
36 Ghali H, Ben Cheikh A, Bhiri S, Khefacha S, Latiri HS, Ben Rejeb M. Trends of Healthcare-associated Infections in a Tuinisian University Hospital and Impact of COVID-19 Pandemic. INQUIRY 2021;58:004695802110679. [DOI: 10.1177/00469580211067930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]